^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Anpingxi (ripertamab)

    i
    Other names: SCT400, SCT-400, SCT 400
    Associations
    News
    Trials
    Company:
    CSPC Pharma, Sinocelltech
    Drug class:
    CD20 inhibitor
    Related drugs:
    Associations
    News
    Trials